DCF — SUMMIT MEDICAL CENTER
Enterprise Value: $201.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$201.6M
Enterprise Value
$45.8M
PV of Cash Flows
$155.8M
PV of Terminal Value
$251.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $545.6M | $33.0M | 6.0% | $5.1M | $4.6M |
| Year 2 | $562.0M | $39.6M | 7.0% | $9.4M | $7.8M |
| Year 3 | $578.8M | $46.6M | 8.0% | $14.1M | $10.6M |
| Year 4 | $596.2M | $51.0M | 9.0% | $16.7M | $11.4M |
| Year 5 | $614.1M | $54.0M | 9.0% | $18.4M | $11.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $201.6M. Terminal value accounts for 77% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$529.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.055477993353665704
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5